PSN Proposes New Measures to Tackle Pharmaceutical Insecurity in Nigeria

The Pharmaceutical Society of Nigeria (PSN) has proposed a series of reforms to address pharmaceutical insecurity in the country, including tighter government supervision of medicine distribution, stronger regulatory enforcement and greater involvement of community pharmacists in identifying suspicious drug activities.

The proposals were among the resolutions reached at the Society’s 99th Annual National Conference, tagged IJELE 2026, held from November 2 to 7 at the International Convention Centre, Awka, Anambra State.

The pharmacists called on the Federal Government to recognize pharmaceutical insecurity as a national security concern, arguing that weaknesses in medicine regulation and distribution could expose the country to drug diversion, illicit trafficking, and the circulation of counterfeit products.

A major recommendation was the replacement of open drug markets with licensed Coordinated Wholesale Centres operating under effective regulatory supervision. The Society maintained that medicine procurement, storage, distribution and dispensing, particularly for controlled substances, require stronger oversight to prevent unauthorised access and diversion.

The PSN also proposed integrating more than 10,000 community pharmacies into Nigeria’s national security framework. Under the arrangement, community pharmacists would serve as frontline stakeholders, helping to identify and report suspicious pharmaceutical activities within their communities.

It further called for the expansion of the National Health Insurance Authority’s Pharmacy First initiative, which could strengthen the role of community pharmacies in providing accessible pharmaceutical services and supporting early identification of health concerns.

To improve the capacity of regulatory institutions, the Society recommended establishing a Special Fund Against Illicit Financial Flows in Healthcare. It proposed that one per cent of assets recovered from drug trafficking activities be allocated to support the enforcement and rehabilitation programmes of the Pharmacy Council of Nigeria (PCN).

The recommendation is intended to provide additional resources for regulatory activities aimed at addressing illegal pharmaceutical operations and strengthening compliance within the sector.

On public-sector medicine procurement, the PSN urged the Federal Government to accelerate the passage of the Federal Drug Revolving Fund and Drug Management Agency Bill. The proposed legislation, which the Society said had passed its first reading at the House of Representatives, is expected to provide a more coordinated framework for purchasing and distributing medicines across federal health institutions.

The Society also raised concerns about the Federal Government’s partnership with Medipool, calling for a review of the existing arrangement with the Federal Ministry of Health. While acknowledging the potential contribution of private companies to financing, technology and procurement, it maintained that government should retain responsibility for critical pharmaceutical functions.

These include medicine quality assurance, procurement decisions, storage, dispensing and the management of controlled medicines. The PSN recommended that private-sector participation should be competitive and non-exclusive, with clear accountability arrangements.

For wider coordination of the proposed reforms, the Society also advocated an independent presidential committee on the pharmaceutical sector, chaired by a registered pharmacist recommended by the PSN. The proposed committee would include representatives of relevant regulatory and research institutions.

The recommendations highlight the Society’s call for a more accountable pharmaceutical system, with stronger public oversight and coordinated action among institutions responsible for medicine safety and distribution.

The PSN’s conference, held under the theme, “One Health, One Pharmacy: Bridging Knowledge, Practice and Policy for National Impact”, brought together stakeholders to discuss challenges and opportunities within Nigeria’s pharmaceutical industry and healthcare system.

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish